Week Ending August 16, 2021

Becoming a Champion for Patients With Lung Cancer
“For months, 50-year-old Lisa Przybyla had a nagging pain in her right shoulder and back that she attributed to exercise and strain. The pain continued to worsen over time and became excruciating when lying down.”

Boosting the power of immunotherapy in lung cancer
“Immune checkpoint blockade (ICB) is a type of immunotherapy approved for lung cancer treatment. Immune checkpoint blockade (ICB) is a class of drugs that can induce CD8 T immune cells to attack tumors.”

New Research Aims to Incorporate PARP Inhibitors in Lung Cancer Treatment
“Ongoing research seeks to determine which biomarker-selected cohorts of patients with lung cancer might respond to PARP inhibitors, shared Sandip Patel, MD, said in a presentation during the 22nd Annual International Lung Cancer Congress®, a program hosted by Physicians’ Education Resource®, LLC.1”

Getting Familiar With Lung Cancer and Its Therapy Options
“Lung cancer is an aggressive form of cancer that is one of the leading causes of death worldwide and in the United States. This disease may affect anyone, including smokers and nonsmokers. However, the rate of cancer in those with no smoking history is lower.”

‘Stigma Kills’: Kathy Griffin’s Diagnosis Brings Lung Cancer Needs to the Forefront, Regardless of Patient Smoking History
“Last week, actress and comedian Kathy Griffin announced that she received a diagnosis of lung cancer, despite having never smoked. Although the American Cancer Society reported that about 16% of lung cancers in women were diagnosed in people who never smoked, the stigma around the disease is still prevalent in our society.”

Lung Cancer Will Never Define Me, But It Has Refined Me
“I never could’ve imagined where my diagnosis with stage 4 EGFR-positive lung cancer would lead. Oh, the things I’ve experienced, the places I’ve gone, and the people I’ve met.”

A Lung Legend
“Dr. Robert Ramirez is a physician at the NOLANETS clinic at Ochsner Health. He has clinical and research interests in lung cancer, specifically non-small cell and small cell cancers, as well as neuroendocrine tumors of the lung, including diffuse, idiopathic, pulmonary, neuroendocrine, cell hyperplasia, typical and atypical carcinoids.”

New advances in treating non-small cell lung cancer
“A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade.”

Lung cancer screening rates mainly unchanged during pandemic
“Stacey A. Fedewa, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined annual LCS rates before and during the pandemic nationally and by state.”

Lung cancer in nonsmokers: How genetic markers can inform treatment
“Certain genetic mutations are more common in lung cancers seen in nonsmokers than in people who smoke. Biomarker testing can point to targeted treatments for specific mutations.”

Lung cancer treatment & living a normal life

VIDEO: ILCC serves as ‘think tank’ for lung cancer experts